AI software integration between EnsoData and Parachute Health aims to connect sleep disorder diagnosis to therapy prescription, improving access for patients, physicians alike
MADISON, WI – May 30, 2024 – Today, EnsoData and Parachute Health announce a partnership to expedite care for newly diagnosed sleep disorders like obstructive sleep apnea (OSA) by simplifying the sleep care workflow from diagnostics through therapy prescription ordering. The two organizations will collaborate to create a seamless handoff from a physician-signed sleep report directly through to durable medical equipment suppliers (DME) using Parachute Health to ensure patients receive access to therapy and help to improve sleep health more quickly.
This partnership aims to directly address the OSA epidemic plaguing patients in the US and around the globe. OSA is an immensely prevalent condition impacting ~39M Americans, yet it is estimated that 80-90% of cases are still undiagnosed today. And even when patients are diagnosed with OSA, only 50% of patients actually receive the appropriate therapy to address and treat the condition.
Together, EnsoData and Parachute Health announce today’s partnership and integration to introduce an efficient, collaborative workflow that ensures patients are both diagnosed and then also receive treatment for sleep apnea more quickly, addressing both the severity of the OSA epidemic and the related workflow challenges in the sleep care continuum.
“We’re excited to partner with Parachute Health to better serve patients, sleep physicians, and DME providers working from a footprint spanning thousands of physicians and major DMEs,” said Justin Mortara, EnsoData President and CEO. “By partnering together, we’re setting ourselves up to support a high volume of patients immediately, with the ability to truly expand the overall impact we can have on patient lives and sleep medicine.”
The Parachute Platform is the largest integrated DME marketplace and enables any supplier and clinician to join, including the more than 220,000 clinicians on Parachute today. The integration with Parachute Health offers sleep labs a way to extend the efficiencies they have gained in diagnosing patients with EnsoSleep to a simple ordering workflow in Parachute. The platform automatically populates order details from the patient sleep study, improving accuracy of prescriptions, eliminating duplicate data entry, and allowing physicians to track patients from their original sleep tests all the way through their prescription fulfillment.
“At Parachute Health, our mission is to give all patients a ‘soft landing,’ with the life-saving products and services they need. By streamlining CPAP ordering at the point of care, we have dramatically improved both the clinician and patient experience,” said David Gelbard, Parachute Health Founder and CEO. “This partnership with EnsoData is an exciting evolution in a series of Parachute partnerships that expand and enhance the Parachute Network and make Parachute Health the industry-leading ePrescribing platform for DME.”
EnsoData and Parachute Health are actively working with early joint customers and expect the integration to be widely available in 2024, paving the way to ensure patients do not fall through the cracks in the care pathway, leading to better patient sleep health, longer lifespans, and better population health for our society at large.
Learn more about Parachute Health:
Parachute Health is the leading ePrescribing platform for digital DME orders, with a network of over 3,000 supplier locations and 220,000 eSigning clinicians across more than 66,000 facilities in all 50 states. The simple DME ordering experience covers 26,000+ unique SKUs on the Parachute Platform to help clinicians create clean digital orders, with transparency into health plan requirements. With a mission to liberate providers from overly complex processes and administrative burdens, Parachute Health’s open platform approach empowers freedom, choice and autonomy. For more information, visit: parachutehealth.com/sign-up.
AI software integration between EnsoData and Parachute Health aims to connect sleep disorder diagnosis to therapy prescription.
